B. Guery

Discipline

Psychologie (1) Economies et finances (1)

Type de document

Articles (25) Recensions (10)

Co-auteur

Date

Source

Mot-clé

Patients (17) Patients (17) Infection (15) Treatment (14) infection (12) Management (10) Human beings (10) antibiotique (8) Antibiotics (8) thérapie (7) Therapeutics (7) Utilization (7) puits (6) hôpital (6) maladie (6) Diagnosis (6) Diagnosis (6) Relapse (6) maladie (6) administration (5) mortalité (5) gestion (5) analyse (5) abords (agglomération) (5) Mortality (5) Cases (5) State, The (5) Population (5) Political science (5) Mortality (5)

Documents écrit par B. Guery (25) | parle de B. Guery (0)

Core genome multilocus sequence typing of Clostridioides difficile to investigate transmission in the hospital setting.
P. Filippidis et al.
Impact of thoracoabdominal imaging on diagnosis and management in patients with suspected infective endocarditis.
M. Papadimitriou-Olivgeris et al.
Long-Term Consequences of COVID-19: A 1-Year Analysis.
L. Bamps et al. (3 avr. 2023)
Clinical significance of concomitant bacteriuria in patients with Staphylococcus aureus bacteraemia.
M. Papadimitriou-Olivgeris et al.
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations.
G. Mitropoulou et al. (31 déc. 2022)
Phagothérapie pour traiter les infections respiratoires [Phage therapy for respiratory infections]
G. Mitropoulou et al. (16 nov. 2022)
Treatment and Outcomes of Clostridioides difficile Infection in Switzerland: A Two-Center Retrospective Cohort Study.
P. Filippidis et al. (30 juin 2022)
Nouveaux antibiotiques ? Perspectives
B. Guery (27 avr. 2022)
Therapeutic drug monitoring of cefepime in a non-critically ill population: retrospective assessment and potential role for model-based dosing.
V. Suttels et al.
A prospective, observational study of fidaxomicin use for Clostridioides difficile infection in France.
B. Guery et al.
Infective endocarditis: prevention and antibiotic prophylaxis.
P. Sendi et al. (15 févr. 2021)
Clostridioides difficile Infection, Still a Long Way to Go.
E. Kampouri et al. (20 janv. 2021)
Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
A. Zimmerli et al. (2021)
Antibiotic-related gut dysbiosis induces lung immunodepression and worsens lung infection in mice.
R. Dessein et al. (15 oct. 2020)
Diagnostic Performance of 18F-FDG PET/CT in Native Valve Endocarditis: Systematic Review and Bivariate Meta-Analysis.
C.H. Kamani et al. (25 sept. 2020)
SARS-CoV-2, un point dans la tourmente [SARS-CoV-2, a point in the storm]
E. Tadini et al. (6 mai 2020)
Nouveaux antibiotiques pour la clinique : un tour d’horizon [New antibiotics for the clinical setting, an overview]
S. Meylan et al. (15 avr. 2020)
Infectiologie: «less is more » [Infectious diseases : « less is more »]
J. Tschopp et al. (15 janv. 2020)
The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks.
R. Enaud et al. (2020)
Predicting Venous Thromboembolic Events in Patients with Coronavirus Disease 2019 Requiring Hospitalization: an Observational Retrospective Study by the COVIDIC Initiative in a Swiss University Hospital.
E. Kampouri et al. (2020)
Microbiological Characterization and Clinical Outcomes After Extended-Pulsed Fidaxomicin Treatment for Clostridioides difficile Infection in the EXTEND Study.
M.H. Wilcox et al.
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses.
O.A. Cornely et al.
How to manage Pseudomonas aeruginosa infections.
M. Bassetti et al. (2018)
Multidrug resistant (or antimicrobial-resistant) pathogens - alternatives to new antibiotics?
A.S. Brunel et al. (2017)
Late recovery of renal failure after autologous haematopoietic stem cell transplantation for multiple myeloma: a report of two cases
N. Bige et al.